image
Novanta Inc. NOVT
Technology - Hardware, Equipment & Parts - NASDAQ - US
Watchlist
$ 105.0
0.845 %
$ 3.78 B
Market Cap
59.32
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one NOVT stock under the worst case scenario is HIDDEN Compared to the current market price of 105 USD, Novanta Inc. is HIDDEN

NOVT Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one NOVT stock under the base case scenario is HIDDEN Compared to the current market price of 105 USD, Novanta Inc. is HIDDEN

NOVT Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one NOVT stock under the best case scenario is HIDDEN Compared to the current market price of 105 USD, Novanta Inc. is HIDDEN

NOVT Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart NOVT

image
1M -27%
6M -69%
1Y -42%
3Y -21%
5Y 30%
All
$190.0$190.0$180.0$180.0$170.0$170.0$160.0$160.0$150.0$150.0$140.0$140.0$130.0$130.0$120.0$120.0$110.0$110.0$100.0$100.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
949 M REVENUE
7.67%
Growth Rates
1Year 7.67%
3Years 10.33%
5Years 8.68%
7Years 8.94%
10Years 10.04%
111 M OPERATING INCOME
0.08%
Growth Rates
1Year 0.08%
3Years 3.33%
5Years 4.39%
7Years 9.88%
10Years 23.98%
64.1 M NET INCOME
-12.06%
Growth Rates
1Year -12.06%
3Years 8.39%
5Years 9.47%
7Years 0.40%
10Years 19.20%
159 M OPERATING CASH FLOW
32.01%
Growth Rates
1Year 32.01%
3Years 18.76%
5Years 20.17%
7Years 13.99%
10Years 14.13%
-208 M INVESTING CASH FLOW
-946.60%
Growth Rates
1Year -946.60%
3Years 12.12%
5Years -26.67%
7Years -2.31%
10Years -8.78%
56.9 M FINANCING CASH FLOW
158.19%
Growth Rates
1Year 158.19%
3Years -34.73%
5Years 75.12%
7Years -12.35%
10Years 3.52%
238 M REVENUE
-2.60%
Growth Rates
1Year 7.67%
3Years 10.33%
5Years 8.68%
7Years 8.94%
10Years 10.04%
26.7 M OPERATING INCOME
-17.96%
Growth Rates
1Year 0.08%
3Years 3.33%
5Years 4.39%
7Years 9.88%
10Years 23.98%
16.5 M NET INCOME
-14.21%
Growth Rates
1Year -12.06%
3Years 8.39%
5Years 9.47%
7Years 0.40%
10Years 19.20%
61.6 M OPERATING CASH FLOW
167.36%
Growth Rates
1Year 32.01%
3Years 18.76%
5Years 20.17%
7Years 13.99%
10Years 14.13%
-2.08 M INVESTING CASH FLOW
50.18%
Growth Rates
1Year -946.60%
3Years 12.12%
5Years -26.67%
7Years -2.31%
10Years -8.78%
-35.6 M FINANCING CASH FLOW
-25.84%
Growth Rates
1Year 158.19%
3Years -34.73%
5Years 75.12%
7Years -12.35%
10Years 3.52%
Balance Sheet Novanta Inc.
image
Current Assets 434 M
Cash & Short-Term Investments 114 M
Receivables 151 M
Other Current Assets 169 M
Non-Current Assets 955 M
Long-Term Investments 0
PP&E 156 M
Other Non-Current Assets 799 M
8.21 %10.88 %12.14 %11.24 %57.53 %Total Assets$1.4b
Current Liabilities 168 M
Accounts Payable 76.9 M
Short-Term Debt 25.2 M
Other Current Liabilities 65.7 M
Non-Current Liabilities 475 M
Long-Term Debt 452 M
Other Non-Current Liabilities 22.5 M
11.96 %3.92 %10.22 %70.39 %3.50 %Total Liabilities$642.8m
EFFICIENCY
Earnings Waterfall Novanta Inc.
image
Revenue 949 M
Cost Of Revenue 528 M
Gross Profit 422 M
Operating Expenses 311 M
Operating Income 111 M
Other Expenses 46.5 M
Net Income 64.1 M
1b1b900m900m800m800m700m700m600m600m500m500m400m400m300m300m200m200m100m100m00949m(528m)422m(311m)111m(46m)64mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
44.41% GROSS MARGIN
44.41%
Averages
1Year 44.41%
3Years 44.58%
5Years 43.52%
7Years 43.15%
10Years 42.88%
11.65% OPERATING MARGIN
11.65%
Averages
1Year 11.65%
3Years 12.05%
5Years 11.96%
7Years 12.23%
10Years 11.28%
6.75% NET MARGIN
6.75%
Averages
1Year 6.75%
3Years 7.87%
5Years 7.66%
7Years 7.54%
10Years 7.96%
8.59% ROE
8.59%
Averages
1Year 8.59%
3Years 10.75%
5Years 10.25%
7Years 10.62%
10Years 11.67%
4.62% ROA
4.62%
Averages
1Year 4.62%
3Years 5.51%
5Years 5.15%
7Years 5.33%
10Years 5.93%
7.19% ROIC
7.19%
Averages
1Year 7.19%
3Years 7.99%
5Years 7.82%
7Years 8.47%
10Years 7.88%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Novanta Inc.
image
160m160m140m140m120m120m100m100m80m80m60m60m40m40m20m20m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 64.1 M
Depreciation & Amortization 55.6 M
Capital Expenditures -17.2 M
Stock-Based Compensation 23.3 M
Change in Working Capital 18.9 M
Others 21.8 M
Free Cash Flow 141 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Novanta Inc.
image
Wall Street analysts predict an average 1-year price target for NOVT of $168 , with forecasts ranging from a low of $160 to a high of $175 .
NOVT Lowest Price Target Wall Street Target
160 USD 52.38%
NOVT Average Price Target Wall Street Target
168 USD 59.52%
NOVT Highest Price Target Wall Street Target
175 USD 66.67%
Price
Max Price Target
Min Price Target
Average Price Target
190190180180170170160160150150140140130130120120110110100100May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 9
6. Ownership
Insider Ownership Novanta Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
3.6 M USD 2
6-9 MONTHS
2.57 M USD 1
9-12 MONTHS
2.05 M USD 3
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Novanta (NOVT) Q4 Earnings Beat Estimates Novanta (NOVT) came out with quarterly earnings of $0.76 per share, beating the Zacks Consensus Estimate of $0.71 per share. This compares to earnings of $0.63 per share a year ago. zacks.com - 1 month ago
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2024 BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the fourth quarter and full year 2024. Financial Highlights Three Months Ended December 31,   Year Ended December 31, (In millions, except per share amounts)   2024       2023       2024       2023   GAAP                       Revenue $ 238.1     $ 211.6     $ 949.2     $ 881.7   O. businesswire.com - 1 month ago
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, February 25, 2025 BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its fourth quarter and full year 2024 results on Tuesday, February 25, 2025. The Company will host a conference call on Tuesday, February 25, 2025, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can. businesswire.com - 2 months ago
Novanta to Present at the CJS Securities 25th Annual New Ideas for the New Year Investor Conference on Tuesday, January 14, 2025 BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that management will be participating at the CJS Securities 25th Annual New Ideas for the New Year Investor Conference on Tuesday, January 14, 2025, which is being held virtually. About Novanta Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equip. businesswire.com - 4 months ago
Novanta to Present at the J.P. Morgan 43rd Annual Healthcare Conference on Monday, January 13, 2025 BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the J.P. Morgan 43rd Annual Healthcare Conference on Monday, January 13, 2025, in San Francisco, California. About Novanta Novanta is a leading global supplier of core technology solu. businesswire.com - 4 months ago
Novanta Inc. (NOVT) Q3 2024 Earnings Call Transcript Novanta Inc. (NASDAQ:NOVT ) Q3 2024 Results Conference Call November 5, 2024 10:00 AM ET Company Participants Ray Nash - Corporate Finance Leader Matthijs Glastra - Chair and Chief Executive Officer Robert Buckley - Chief Financial Officer Conference Call Participants Lee Jagoda - CJS Securities Brian Drab - William Blair Rob Mason - Baird Operator Good morning. My name is Gary, and I will be your conference operator today. seekingalpha.com - 5 months ago
Novanta (NOVT) Q3 Earnings Miss Estimates Novanta (NOVT) came out with quarterly earnings of $0.85 per share, missing the Zacks Consensus Estimate of $0.86 per share. This compares to earnings of $0.85 per share a year ago. zacks.com - 5 months ago
Novanta Announces Financial Results for the Third Quarter 2024 BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the third quarter 2024. Financial Highlights Three Months Ended   (In millions, except per share amounts) September 27,     September 29,     2024     2023   GAAP           Revenue $ 244.4     $ 221.5   Operating Income $ 32.6     $ 30.3   Net Income $ 19.2     $ 21.2   Diluted EPS. businesswire.com - 5 months ago
Novanta to Present at the Baird 2024 Global Industrial Conference on Wednesday, November 13, 2024 BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer is scheduled to present at the Baird 2024 Global Industrial Conference on Wednesday, November 13, 2024, in Chicago, Illinois. About Novanta Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original. businesswire.com - 6 months ago
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 5, 2024 BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2024 results on Tuesday, November 5, 2024. The Company will host a conference call on Tuesday, November 5, 2024, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed onli. businesswire.com - 6 months ago
4 Top Electronics Stocks With Bright Industry Prospects to Buy The Zacks Electronics - Miscellaneous Components industry players like FN, NOVT, OSIS and AMSC are set to gain from the solid adoption of AI and the democratization of IoT techniques. zacks.com - 7 months ago
3 Robotics Stocks to Buy and Hold for the Potential of Huge Returns I am fascinated by robots. From an investment standpoint, robotics looks to be the natural complement to AI's advancement. investorplace.com - 8 months ago
8. Profile Summary

Novanta Inc. NOVT

image
COUNTRY US
INDUSTRY Hardware, Equipment & Parts
MARKET CAP $ 3.78 B
Dividend Yield 0.00%
Description Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. It's Vision segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless technologies, video recorders, and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. In addition, its Precision Motion segment offers optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles. The company sells its products through its direct sales force, resellers, distributors, and system integrators under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was founded in 1968 and is headquartered in Bedford, Massachusetts.
Contact 125 Middlesex Turnpike, Bedford, MA, 01730 https://www.novanta.com
IPO Date March 24, 1999
Employees 3000
Officers Mr. Robert J. Buckley Chief Financial Officer Ms. Nissia Sabri Senior Vice President of Corporate Development Mr. John Lesica Co-Chief Operating Officer of Medical Solutions Mr. Matthijs Glastra Chief Executive Officer & Chairman of the Board Mr. John Joseph Burke II Chief Accounting Officer & Corporate Controller Mr. Ray Nash Corporate Finance Leader & IR Ms. Sarah Betadam Chief Information Officer & Chief Information Security Officer Ms. Anna Fain Senior Vice President of Leadership Development and Diversity, Equity & Inclusion Mr. Chuck Ravetto Co-Chief Operating Officer of Automation Enabling Technologies Ms. Michele Davis Michele Welsh General Counsel & Corporate Secretary